Could a mushroom extract boost lung cancer treatment?
NCT ID NCT07197853
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether adding Huaier granules (a traditional Chinese medicine) to microwave ablation improves outcomes for people with stage IA non-small cell lung cancer who cannot have surgery. 180 participants will be randomly assigned to receive ablation alone or ablation plus Huaier granules for 72 weeks. The study will measure progression-free survival, tumor control, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Huaier granules (a traditional Chinese medicine extract) and microwave ablation
What this could lead to
If successful, this combination could offer a more effective treatment option for people with early-stage lung cancer who cannot have surgery, potentially improving tumor control and survival.
What could go wrong
This is a single-center trial, so results may not apply broadly. The addition of Huaier granules may not provide significant benefit over ablation alone, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••